Volume 47, Issue 12 pp. 2223-2229
ORIGINAL ARTICLE

Comparison of vancomycin area under the concentration-time curve (AUC) using two-point pharmacokinetics versus two open-access online single-concentration vancomycin calculators

Nicole M. Ondrush PharmD

Nicole M. Ondrush PharmD

The Mount Sinai Hospital, One Gustave L. Levy Place, New York, USA

Search for more papers by this author
Rejs Ademovic PharmD

Rejs Ademovic PharmD

Upstate University Hospital, Syracuse, New York, USA

Search for more papers by this author
Robert W. Seabury PharmD, BCPS, DABAT

Robert W. Seabury PharmD, BCPS, DABAT

Upstate University Hospital, Syracuse, New York, USA

Search for more papers by this author
William Darko B.Pharm, PharmD, BCCCP

William Darko B.Pharm, PharmD, BCCCP

Upstate University Hospital, Syracuse, New York, USA

Search for more papers by this author
Christopher D. Miller PharmD, BCPS

Christopher D. Miller PharmD, BCPS

Upstate University Hospital, Syracuse, New York, USA

Search for more papers by this author
Bryan T. Mogle PharmD, BCPS

Corresponding Author

Bryan T. Mogle PharmD, BCPS

Upstate University Hospital, Syracuse, New York, USA

Correspondence

Bryan T. Mogle, PharmD, Department of Pharmacy, 750 E Adams Street, Syracuse, NY 13210, USA.

Email: [email protected]

Search for more papers by this author
First published: 09 November 2022

Abstract

What Is Known and Objective

Current vancomycin monitoring guidelines recommend the use of area under the concentration-time curve (AUC24) monitoring in patients with serious Methicillin-Resistant Staphylococcus aureus (MRSA) infections by utilizing either a Bayesian approach or first-order analytic equations. Several open-access websites exist that allow estimation of vancomycin AUC24 with the use of a single steady-state concentration. It is uncertain how these open-access calculators perform against guideline-recommended methods. The objective was to compare AUC24 estimates from two online, open-access, single-concentration vancomycin calculators compared with the two-point pharmacokinetic (2PK) method.

Methods

AUC24 estimates were made using the 2PK reference method and the single-concentration vancomycin calculators, ClinCalc and VancoPK. The AUC24 estimates from the 2PK reference method were compared to the online calculators by assessing bias (median AUC24 difference) and precision (AUC24 difference ± 100 mg*h/L). Clinical precision was also assessed by characterizing the frequency that the 2PK reference method and the online calculators showed clinical disagreement based on the following AUC24 categories: (1) AUC24 < 400 mg*h/L; (2) AUC24 400–600 mg*h/L and (3) AUC24 > 600 mg*h/L.

Results and Discussion

A total of 253 patients were included in the study. The AUC24 estimates from the ClinCalc and VancoPK single-concentration vancomycin calculators showed some bias and imprecision, though VancoPK appeared to have less. Clinical disagreement versus the 2PK reference method occurred in 31.2% and 19.4% of AUC24 estimates from the ClinCalc and VancoPK single-concentration vancomycin calculators, suggesting clinical imprecision.

What Is New and Conclusion

The AUC24 estimates from single-concentration, online vancomycin calculators showed some bias and imprecision in comparison to the 2PK method. Institutions should validate these online, trough-only calculators relative to a 2PK method in their patient populations prior to adoption as standard-of-care.

CONFLICT OF INTEREST

The authors have no conflicts of interest.

DATA AVAILABILITY STATEMENT

The data that support the findings of this study are available from the corresponding author, [BTM], upon reasonable request.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.